MedTrace Logo

Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders

NCT02663206 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-01-12

No results posted yet for this study

Summary

To compare the efficacy of peroral endoscopic myotomy and Botulinum toxin injection in spastic esophageal disorders.

Conditions

  • Esophageal Achalasia
  • Esophageal Spasm, Diffuse
  • Esophageal Motility Disorders

Interventions

PROCEDURE

peroral endoscopic myotomy

peroral endoscopic myotomy

PROCEDURE

Botulinum toxin injection

endoscopic Botulinum toxin (BTX) injection at lower esophagus

Sponsors & Collaborators

Principal Investigators

  • Mouen A Khashab, MD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02663206 on ClinicalTrials.gov